BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 27137657)

  • 1. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
    Hoang T; Lambert JA; Martin R
    Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
    Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
    PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
    Gering M; Yamada Y; Rabbitts TH; Patient RK
    Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of endoglin overexpression during embryoid body development.
    Baik J; Borges L; Magli A; Thatava T; Perlingeiro RC
    Exp Hematol; 2012 Oct; 40(10):837-46. PubMed ID: 22728030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
    El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
    Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF.
    Pearson S; Sroczynska P; Lacaud G; Kouskoff V
    Development; 2008 Apr; 135(8):1525-35. PubMed ID: 18339678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer.
    Nottingham WT; Jarratt A; Burgess M; Speck CL; Cheng JF; Prabhakar S; Rubin EM; Li PS; Sloane-Stanley J; Kong-A-San J; de Bruijn MF
    Blood; 2007 Dec; 110(13):4188-97. PubMed ID: 17823307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of TAL1 in Hematopoiesis and Leukemogenesis.
    Vagapova ER; Spirin PV; Lebedev TD; Prassolov VS
    Acta Naturae; 2018; 10(1):15-23. PubMed ID: 29713515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver.
    Landry JR; Kinston S; Knezevic K; de Bruijn MF; Wilson N; Nottingham WT; Peitz M; Edenhofer F; Pimanda JE; Ottersbach K; Göttgens B
    Blood; 2008 Mar; 111(6):3005-14. PubMed ID: 18184866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
    McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
    Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesodermal patterning activity of SCL.
    Ismailoglu I; Yeamans G; Daley GQ; Perlingeiro RC; Kyba M
    Exp Hematol; 2008 Dec; 36(12):1593-603. PubMed ID: 18809240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells.
    Park C; Afrikanova I; Chung YS; Zhang WJ; Arentson E; Fong Gh Gh; Rosendahl A; Choi K
    Development; 2004 Jun; 131(11):2749-62. PubMed ID: 15148304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
    Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
    PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCL/TAL1: a multifaceted regulator from blood development to disease.
    Porcher C; Chagraoui H; Kristiansen MS
    Blood; 2017 Apr; 129(15):2051-2060. PubMed ID: 28179281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCL interacts with VEGF to suppress apoptosis at the onset of hematopoiesis.
    Martin R; Lahlil R; Damert A; Miquerol L; Nagy A; Keller G; Hoang T
    Development; 2004 Feb; 131(3):693-702. PubMed ID: 14729577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic Runx1 expression rescues Tal-1-deficiency in the generation of primitive and definitive hematopoiesis.
    Tornack J; Seiler K; Grützkau A; Grün JR; Onodera M; Melchers F; Tsuneto M
    PLoS One; 2013; 8(7):e70116. PubMed ID: 23922928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building multifunctionality into a complex containing master regulators of hematopoiesis.
    Fujiwara T; Lee HY; Sanalkumar R; Bresnick EH
    Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20429-34. PubMed ID: 21059912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of retinoic acid and scl controls primitive blood development.
    de Jong JL; Davidson AJ; Wang Y; Palis J; Opara P; Pugach E; Daley GQ; Zon LI
    Blood; 2010 Jul; 116(2):201-9. PubMed ID: 20410509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCL-GFP transgenic zebrafish: in vivo imaging of blood and endothelial development and identification of the initial site of definitive hematopoiesis.
    Zhang XY; Rodaway AR
    Dev Biol; 2007 Jul; 307(2):179-94. PubMed ID: 17559829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1.
    Lécuyer E; Herblot S; Saint-Denis M; Martin R; Begley CG; Porcher C; Orkin SH; Hoang T
    Blood; 2002 Oct; 100(7):2430-40. PubMed ID: 12239153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.